WVE
Wave Life Sciences LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.45B
P/E Ratio
—
EPS
$-1.05
Beta
-1.32
52W High
$21.73
52W Low
$5.02
50-Day MA
$10.38
200-Day MA
$10.22
Dividend Yield
—
Profit Margin
-255.70%
Forward P/E
—
PEG Ratio
0.00
About Wave Life Sciences Ltd
Wave Life Sciences Ltd., a clinical-stage genetic medicine company, designs, optimizes and produces new stereopure oligonucleotides through PRISM, a drug discovery and development platform. The company is headquartered in Singapore.
Fundamentals
| Revenue (TTM) | $71.80M |
| Gross Profit (TTM) | $-110.98M |
| EBITDA | $-193.47M |
| Operating Margin | -81.80% |
| Return on Equity | -53.10% |
| Return on Assets | -28.20% |
| Revenue/Share (TTM) | $0.40 |
| Book Value | $2.76 |
| Price-to-Book | 2.83 |
| Price-to-Sales (TTM) | 20.15 |
| EV/Revenue | 12.78 |
| EV/EBITDA | -10.12 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 316.90% |
| Shares Outstanding | $192.38M |
| Float | $127.00M |
| % Insiders | 13.90% |
| % Institutions | 92.02% |
Analyst Ratings
Consensus ($24.93 target)
2
Strong Buy14
BuyData last updated: 4/29/2026